Prof. Francis Otunta, the Vice Chancellor (VC), Michael Okpara University of Agriculture, Umudike, in Abia, has confirmed the discovery of a new drug for the treatment and cure of HIV/AIDS. Otunta told newsmen at the university campus on Wednesday that the finding followed years of scientific research by the institution.

He said that the breakthrough was made by Prof. Maduike Ezeibe, a researcher in the university. According to him, Ezeibe had presented the drug to the University management, Senate and Council, where he explained the processes he went through to arrive at his finding.

The VC also said that Ezeibe had equally presented the drug to his colleagues in the medical field and nobody had contradicted his finding. “Prof. Ezeibe is a researcher in Veterinary Medicine and one may wonder how he discovered a drug to cure a human ailment,” he said. He commended Ezeibe for the breakthrough, saying: “He has brought honour to the University and we are proud of him.” Otunta said that the university was in the process of mass producing the drug for further clinical trials on persons living with HIV/AIDS in the country. Ezeibe, who is a professor of Veterinary Medicine and Clinical Virology, said that the drug was produced with Aluminum Silicate and Magnesium Silicate (Synthetic Aluminum-Magnesium Silicate). He said that the two minerals “are already in use as medicines for the treatment of various animal and human diseases”. He said that 10 persons living with the disease, “who volunteered’’, were made to apply through their doctor to the VC. “They were treated daily with the Medicinal Synthetic Aluminum-Magnesium Silicate (50 mg/kg),” he said. Ezeibe said that the volunteers were subjected to monthly tests for viral loads and CD4-lymphocyte counts. “With the antiviral effects of the medicine, its ability to reach all cells (as nanoparticles) and the lymphocytes, there is no more hiding place (sanctuary) for HIV,” he said. He said that the medicine had been used to potentiate Ampicilin, Chloroquine, Piperazine and Sulphadimidin, among others, and could be a major foreign exchange earner for Nigeria, if approved by relevant authorities. According to him, “local and international pharmaceutical companies would find the product as a veritable raw material”. Ezeibe said that he presented the research findings to the World Virology Conference in Atlanta in 2015, and Antonio (Texas) in 2016. Besides, he said that the results of the laboratory tests had been published in many international scientific journals, including the British Journal of Medicine and Medical Research, among several others. He said that he was also about to sign a memorandum of understanding with a U.S.-based Scientific Research Publishing, publishers of World Journal of AIDS, for the publication of his book “How I came about the cure for HIV/AIDS”. Ezeibe, who said that the medicine was patented in August 2014 in Nigeria, called on the Federal Government to help him to secure international patency for the drug. He said: “If commercialised, the Medicinal Synthetic Aluminum-Magnesium Silicate would become an alternative for petroleum to the Nigerian economy.”

Read more at: http://www.vanguardngr.com/2017/02/breakthrough-michael-okpara-varsity-discovers-cure-hivaids/

Read more at: http://www.vanguardngr.com/2017/02/breakthrough-michael-okpara-varsity-discovers-cure-hivaids/

Ok

Hmmm

My Alma mater

Prof Otunta (Prof mini pusy)

This is a Major breakthrough! Why isn't it on front page? We ought to celebrate our own. This breakthrough has the ability to earn massive foreign exchange. God bless Prof. Maduike Ezeibe.

TheObservatory:
This is a Major breakthrough! Why isn't it on front page? We ought to celebrate our own. This breakthrough has the ability to earn massive foreign exchange. God bless Prof. Maduike Ezeibe.

Maduike Ezeibe has not cured AIDSI mean, it feels ridiculous to me that I need to say this, but since this website is apparently full of bizarre AIDS-conspiracy theorists who think ‘the government’ will kill this man for publishing his quack science, I put together a few points to hopefully clear things up.The claim that his treatment has cured AIDS is completely unfounded.In his June 2015 paper,Ezeibe writes:Also, reduction of mean viral load of all the HIV/AIDS patients who participated in the clinical trial, from 18875.00 ± 17059.18 to 327.50 ± 226.84, is 98.26% reduction. Kaplan [27] reported thatwhen treatments reduce loads of infectious agents by 95% or more, body immunity is able to eliminate what are left of the infections.What these results mean, is that the MSAMS cures HIV/AIDS, not just prolongation of lives of HIV-positive persons.It’s embarrassing that I am using my fandom blogto tear this down, but that Kaplan paper cited is aboutparasitic worms. The fact that someone decided that a treatment threshold for parasitic worms could a) be applied to HIV and b) used to claim they found a cure should honestly discredit their entire body of work on the topic.Anyone who has reada n y t h i n gabout HIV in the past decade knows that that’s not how HIV fucking works. Every real antiretroviral treatment on the market today can achieve non-detectable levels of virus in a fraction of patients with good compliance, but whole reason HIV continues to be an issue today is that the virus hangs out inside your non-replicating dendritic cells or wherever and itfucking comes backwhen you stop treatment. To eventhinkabout claiming a cure for HIV, patients need to be off treatment and virus-free for YEARS. To date the only person to be really actually cured of HIV is theBerlin Patient, who was cured with a bone marrow transplant from a donor with HIV-resistant T-cells. Repeat after me: the only successful way to cure HIV is to kill off 100% of your immune cells and replace them with immune cells that HIV can’t infect.So how did Ezeibe get away with making truly laughable claims in a scientific journal?The paper is published in a trash journal.Scientific journals are rated by, among other metrics, theirImpact Factor. This describes how many times an article in that journal will be cited in the future, telling you essentially how much that paper contributed to other people’s works. Scientists want their work to have impact. Top journals like Nature, Science, New England Journal of Medicine, etc. have Impact Factors in the 30s. These journals publish the most exciting,high-impact results that scientists across disciplines are interested in and they correspondingly have the most rigorous scientificrequirements for accepting articles. A journal with Impact Factor of 2 to 4 might be a nice nichejournal with decent rigor (like JIAS for example) but won’t be read by anyone outside that particular field of study. What, you may ask, is theImpact Factor for World Journal of AIDS, the journal where Ezeibe’s article is published?ZERO.ResearchGate lists their IF as 0. Is that the default for journals with no data? Seems so. WJA apparently doesn’t have an official IF score, (because Thompson Reuters doesn’t deem them to be even significant enough to score among the70 Infectious Disease journals and 139 Immunology journalsthey scored in 2013) but theygenerously calculate their own alternative score to beless than one.I honestly can’t critique his paper in more detail than this because his methods section is almost nonexistent. It’spossiblethat his nanoparticle therapy for HIV has promise, but it’s impossible to tell from this paper. For what is ostensibly a Phase I clinical trial for his “miracle drug,” any journal with any reputation at all to uphold is sending this submission back with request for MAJOR revisions, or more likely rejecting it outright.Bottom line: no one is reading or citing WJA except by accident. The news outlets reporting onthis paper need to fire their science correspondents.One last general thing:HIV/AIDS is not a neglected disease.A lot of the reblogs of the original post seem to suggest that “no one will hear about this” because of the racism and homophobia that intersect with HIV/AIDS, and that Ezeibe is lacking funding to take his miracle cure into next stage trials because no one cares about HIV/AIDS anymore. Let me be clear: people with HIV face a million different types of stigma and discrimination, much of it connected to homophobia and racism, butLACK OF RESEARCH FUNDING IS NOT ONE OF THEM. HIV/AIDS receives$3 BILLIONin annual funding from the NIH,the most of any single disease.This isn’t the 1980s anymore. Scientists fucking LOVE studying HIV. We literallyknow so much about this stupid virus that we are using it as adelivery system to bioengineer treatments for cancer. There are loads of brilliant scientists working on a cure for HIV. There are loads of brilliant African scientists working on a cure for HIV. Maduike Ezeibe is not one of them.